1 reports of this reaction
12.5% of all ZINC OXIDE SUNSCREEN reports
#6 most reported adverse reaction
SKIN EXFOLIATION is the #6 most commonly reported adverse reaction for ZINC OXIDE SUNSCREEN, manufactured by Bausch Health US, LLC. There are 1 FDA adverse event reports linking ZINC OXIDE SUNSCREEN to SKIN EXFOLIATION. This represents approximately 12.5% of all 8 adverse event reports for this drug.
Patients taking ZINC OXIDE SUNSCREEN who experience skin exfoliation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SKIN EXFOLIATION is a frequently reported adverse event for ZINC OXIDE SUNSCREEN, accounting for a significant proportion of all reports.
In addition to skin exfoliation, the following adverse reactions have been reported for ZINC OXIDE SUNSCREEN:
The following drugs have also been linked to skin exfoliation in FDA adverse event reports:
SKIN EXFOLIATION has been reported as an adverse event in 1 FDA reports for ZINC OXIDE SUNSCREEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
SKIN EXFOLIATION accounts for approximately 12.5% of all adverse event reports for ZINC OXIDE SUNSCREEN, making it a notable side effect.
If you experience skin exfoliation while taking ZINC OXIDE SUNSCREEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.